Related Experiment Video
Updated: Jun 6, 2026
09:34
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
Cancer chemotherapy with lipid-based nanocarriers
1School of Pharmaceutical Science, Shandong University, China.
Critical Reviews in Therapeutic Drug Carrier Systems
|November 19, 2010
Summary
Lipid-based nanocarriers offer promising solutions for enhancing anticancer drug delivery, overcoming limitations like poor solubility and toxicity. These advanced carriers are poised to improve cancer treatment efficacy, specificity, and safety in the near future.
Area of Science:
- Nanomedicine and Drug Delivery
- Oncology
- Materials Science
Background:
- Nanotechnology significantly impacts scientific research, with a growing focus on therapeutic applications, particularly in cancer treatment.
- Lipid-based nanocarriers are gaining attention for their potential in delivering anticancer drugs, addressing challenges associated with conventional therapies.
- Existing anticancer compounds often suffer from poor solubility, normal tissue toxicity, lack of specificity, and drug resistance, necessitating novel delivery systems.
Purpose of the Study:
- To review the advantages and methodologies of utilizing nanocarriers for improved cancer treatment efficiency.
- To present various types of lipid-based nanocarriers and identify current research hotspots.
- To highlight the potential of lipid-based nanocarriers in overcoming limitations of traditional anticancer drug delivery.
Main Methods:
- Literature review of scientific publications on nanotechnology and cancer therapeutics.
- Analysis of the role of lipid-based nanocarriers in drug formulation and delivery.
- Identification and discussion of different types of lipid-based nanocarriers and their applications.
- Highlighting current research trends and future directions in the field.
Main Results:
- Lipid-based nanocarriers demonstrate significant potential in improving the therapeutic efficacy of anticancer drugs.
- These nanocarriers can effectively address common shortcomings of anticancer compounds, including poor solubility, toxicity, and drug resistance.
- Various types of lipid-based nanocarriers are being explored, with ongoing research focusing on optimizing their properties for targeted delivery.
Conclusions:
- Lipid-based nanocarriers are a promising platform for enhancing anticancer drug delivery, offering improved specificity and reduced toxicity.
- Further advancements in lipid-based nanocarrier technology are expected to lead to more efficient and safer cancer treatments.
- The strategic use of nanocarriers represents a significant step forward in the field of oncology and nanomedicine.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.